dm+d
85272000
Articles
Using calcium-channel blockers during breastfeeding
2 June 2023Nifedipine and verapamil are the CCBs of choice. Recommendations apply to full term and health infant only.
Managing peripheral oedema caused by calcium channel blockers
26 September 2022All calcium channel blockers may cause peripheral oedema. There are different treatment options and the incidence can be affected by different factors.
Example medicines to prescribe by brand name in primary care
27 March 2022Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.
Medicine Compliance Aid Stability
Coracten SRUCB Pharma Ltd
UCB Pharma Ltd
Coracten SR
Capsules m/r 10mg, 20mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022
Valni XLZentiva
Zentiva
Valni XL
Tablets m/r 30mg, 60mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022
Fortipine LAADVANZ pharma
ADVANZ pharma
Fortipine LA
Tablets m/r 40mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022
Nifedipress MRDexcel Pharma Ltd
Dexcel Pharma Ltd
Nifedipress MR
Tablets m/r 10mg, 20mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022
Coracten XLUCB Pharma Ltd
UCB Pharma Ltd
Coracten XL
Capsules 30mg, 60mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Protect from light.
10 October 2022
Adipine MRThornton & Ross Ltd
Thornton & Ross Ltd
Adipine MR
Tablets m/r 10mg, 20mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022
Tensipine MRGenus Pharmaceuticals
Genus Pharmaceuticals
Tensipine MR
Tablets m/r 10mg, 20mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022
Adalat LABayer plc
Bayer plc
Adalat LA
Tablets m/r 20mg, 30mg, 60mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022
Adipine XLChiesi Ltd
Chiesi Ltd
Adipine XL
Tablets m/r 30mg, 60mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Nifedipine is very light sensitive
10 October 2022
Lactation Safety Information
-
Moderate published evidence of safety
Extensive experience of safe use in breastfeeding
Small amounts in breast milk
No adverse effects reported in breastfed infants
Used in infants >1 month
Preferred choice during breastfeeding for treating Raynaud’s syndrome
16 January 2017